Overview of Lemsip Max Cold & Flu

Property	Description
Active Ingredient	Acetaminophen, Phenylephrine Hydrochloride
Form	Powder for Oral Solution (Hot Drink)
Pharmacological Class	Analgesic, Antipyretic, Sympathomimetic
General Purpose	Symptomatic relief of cold and flu
Origin	Synthetic, Fixed-Dose Combination

Lemsip Max Cold & Flu is a widely recognized multicomponent Over-The-Counter (OTC) medicine formulated for the systemic management of discomfort associated with common cold and flu symptoms. The preparation is distinctively presented as a Powder for Oral Solution, designed for dissolution into a warm beverage and oral administration, offering a soothing delivery method. This product is classified as a Fixed-Dose Combination drug, integrating two active ingredients to ensure multiple symptoms are targeted simultaneously.

Composition and Classification: The Analgesic, Antipyretic, and Decongestant Combination

The medicine's composition is based on the combination of Acetaminophen (Paracetamol) and Phenylephrine Hydrochloride. Acetaminophen is clinically recognized as both an Analgesic (pain relief) and Antipyretic (fever reduction). Complementing this action, Phenylephrine Hydrochloride belongs to the Sympathomimetic class, utilized for its targeted action as a Nasal Decongestant. The combined use of these agents is intended for relieving the characteristic symptoms of congestion, headache, and body aches that typify cold and flu.

General Purpose: Why Use a Synchronized Cold and Flu Formula?

The primary purpose of this combination product is to offer synchronized symptomatic relief through the delivery of multiple effects throughout the body. While the Acetaminophen component manages systemic discomforts like muscle pain and fever, the Phenylephrine works by causing vasoconstriction in the nasal lining to alleviate congestion. This combined, systemic effect diminishes the overall symptom burden caused by cold and flu discomfort, providing a comprehensive approach to improving general patient comfort, such as when experiencing nasal congestion and a feverish headache before bedtime.

Regulatory References

NIH MedlinePlus

What side effects are possible with Lemsip Max Cold & Flu?

Possible side effects and safety information

Adverse reactions associated with this medicine are structured by physiological systems and categorized by frequency, based on official regulatory documents.

Classification Scope	Categories and Examples (As per Regulatory Labels)
Adverse Reaction Categories	The safety profile primarily involves Cardiovascular (e.g., hypertension, palpitations), Nervous System (e.g., insomnia, anxiety), Dermatological (e.g., skin rash), and Hematological effects.
Frequency Classification	Very Rare incidents include serious skin reactions (e.g., Stevens-Johnson syndrome). Most effects, such as blood disorders and nervous system reactions, are classified as Not Known frequency.
System-Organ Classes	Effects are officially grouped under Blood and Lymphatic, Immune System, Psychiatric, Nervous System, Cardiac, Vascular, Gastrointestinal, Skin, and Renal and Urinary disorders.

Serious Adverse Reactions and Safety Considerations

The regulatory safety profile highlights several serious risks associated with the active ingredients:

Severe Hepatotoxicity: The risk of severe liver damage or acute liver failure is the main concern associated with Acetaminophen, particularly following excessive intake.
Serious Skin Reactions: Rare, severe, and potentially fatal dermatological reactions (e.g., Toxic Epidermal Necrolysis) have been reported.
Cardiovascular Events: The Phenylephrine component carries a risk of Hypertension (increased blood pressure) and Irregular Heartbeat.

Official safety statements advise caution for specific populations. Patients with severe hepatic or severe renal impairment have an increased risk of toxicity. Older adults may be more sensitive to the sympathomimetic effects of Phenylephrine. The adverse event of urinary retention is noted as occurring especially in males due to underlying conditions like prostatic hypertrophy. Use during pregnancy is advised against due to the possible association of fetal abnormalities with phenylephrine exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for this combination medicine is defined by the toxicological hazards of both Acetaminophen and Phenylephrine Hydrochloride, requiring immediate action. Acetaminophen over-exposure poses the primary severe risk, involving time- delayed hepatic toxicity that can progress to hepatic failure, encephalopathy, and death. Initial signs, such as nausea, vomiting, pallor, and abdominal pain, may be mild or even absent, and liver damage may not become apparent until 24 to 48 hours post-ingestion.

The Phenylephrine component can result in sympathomimetic manifestations, including headache, sleeplessness ( insomnia), dizziness, and hypertension [2.6]. In severe cases, cardiovascular collapse and respiratory depression may occur. The risk of Acetaminophen-related liver damage is greater in individuals with non- cirrhotic alcoholic liver disease.

Regulatory authorities mandate that immediate medical attention must be sought for any suspected overdose, even if the patient feels well. This is critical because Acetaminophen toxicity is treatable with the antidote N- acetylcysteine ( NAC), which is most effective when administered within eight hours of ingestion. Management may involve activated charcoal or gastric lavage in the first hour, followed by symptomatic and supportive measures for Phenylephrine over-exposure.

Therapeutic Uses of Lemsip Max Cold & Flu

Lemsip Max Cold & Flu is commonly used to provide symptomatic relief during the acute or disruptive episodes of the common cold and flu, targeting the key symptom clusters that interfere with daily stability. The medicine is applied across domains where short-term symptomatic support is appropriate. It helps address symptom clusters related to inflammatory or irritative states, including headache, muscle pain, elevated feverishness, and nasal congestion.

Relief of Systemic Pain and Febrile Discomfort

The medication is commonly used across conditions presenting with acute episodes and helps address symptoms related to physical discomfort and systemic imbalance. This provides support that contributes to easing the overall symptom load related to systemic imbalance. Quick Fact: Relief for Aches and Fever

Management of Acute Nasal and Sinus Congestion

Applied in scenarios where additional management of discomfort is required, this product is relevant for managing symptoms that create noticeable physiological strain, specifically those linked to temporary nasal congestion. It helps address symptom clusters that may become intense, such as a blocked nose and the feeling of pressure associated with irritated nasal passages, thereby contributing to improved day-to-day comfort during symptomatic periods.

“This medication is applied in clinical settings that involve acute or disruptive symptom patterns, and is used across domains where short-term symptomatic assistance is appropriate.”

Coordinated Multi-Symptom Support

The fixed combination is relevant in contexts involving a heightened systemic burden, specifically when multiple symptoms occur together. It assists with maintaining functional stability by providing supportive relief that helps patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lemsip Max Cold & Flu?

The population eligibility for Lemsip Max Cold & Flu is strictly defined by regulatory documents, primarily based on contraindications related to its active ingredients, Paracetamol and Phenylephrine Hydrochloride.

Contraindicated Populations (Must Not Use)

The medicine is contraindicated in patients with a known hypersensitivity to the ingredients or those with specific pre-existing conditions. Absolute contraindications include severe heart disease, hypertension (high blood pressure), hyperthyroidism, Phaeochromocytoma, and closed-angle glaucoma. Individuals with severe hepatic impairment (severe liver problems) or diabetes mellitus are also prohibited from use. This product must not be given to patients currently taking or having recently stopped (within 14 days) Monoamine Oxidase Inhibitors (MAOIs) or other sympathomimetic decongestants.

Age and Physiological Restrictions

Lemsip Max Cold & Flu is contraindicated for children under 16 years of age; it is only indicated for adults and adolescents 16 years and over. Use is strongly restricted during pregnancy and breastfeeding, and should be avoided unless medical advice is received. Care is advised for patients with severe renal impairment (severe kidney problems).

What should I know about interactions with other medicines?

The official interaction profile for Lemsip Max Cold & Flu is defined by regulatory constraints related to its active ingredients: Acetaminophen (Paracetamol) and Phenylephrine Hydrochloride.

Interaction Type	Interacting Agent	Official Regulatory Statement
Contraindicated	Monoamine Oxidase Inhibitors (MAOIs)	Must not be used in patients currently taking MAOIs or within 14 days of cessation due to the risk of severe hypertensive reactions.
Pharmacodynamic	Other Sympathomimetic Agents	Concomitant use is prohibited due to additive pressor effects, which increases the risk of hypertension.
Pharmacodynamic	Antihypertensives (e.g., Beta-blockers)	Phenylephrine may reduce the efficacy of these medicines.
Exposure-Altering	Warfarin and other Coumarins	The anticoagulant effect may be enhanced by prolonged regular daily use of the Acetaminophen component, increasing bleeding risk.
Exposure-Altering	Cholestyramine	This substance may officially reduce the absorption of Acetaminophen.
Exposure-Altering	Metoclopramide, Domperidone	These medicines may officially increase the rate of Acetaminophen absorption.
Metabolic Risk	Alcohol, Liver Enzyme-Inducing Drugs	May increase the officially documented hepatotoxic potential of the Acetaminophen component.
Pharmacodynamic	Cardiac Glycosides, Oxytocic Agents	Use with Phenylephrine is documented to increase the official risk of irregular heartbeat or potentiate vasopressor effects.

The resulting interaction structure establishes absolute restrictions for co-administration with MAOIs and other pressor amines, while defining conditional use requirements for anticoagulant therapy. The official statements further classify substances that modify Acetaminophen exposure or clearance.

Mechanism of Action

Central Modulation of Temperature and Pain Control

This domain addresses the action of Acetaminophen (Paracetamol), which modulates central processes by selectively inhibiting Cyclooxygenase ( COX) enzymes within the Central Nervous System ( CNS). This targeted inhibition reduces the synthesis of Prostaglandin E2 ( PGE2 ) in the hypothalamus and influences nociceptive signaling pathways. The resulting physiological effect is a lowering of the thermal set point and an elevation of the pain threshold.

Peripheral Adrenergic Vasoconstriction

This mechanism is governed by Phenylephrine, a direct agonist at mathbfalpha1 -Adrenergic Receptors located on the vascular smooth muscle in the nasal lining. By activating these receptors, the drug initiates a signaling cascade that results in the contraction of blood vessel walls (vasoconstriction). This action diminishes blood flow and lowers capillary hydrostatic pressure in the nasal tissues. The core physiological consequence is a reduction in tissue edema.

Mechanistic Coordination of Central and Local Systems

The drug's overall profile is achieved through the complementary action of its two mechanisms on entirely separate biological systems—the CNS and the peripheral vasculature. This fixed combination is used to influence two distinct domains simultaneously, ensuring the regulation of central physiological parameters and the adjustment of localized vascular tone occur in parallel. This coordinated approach simultaneously addresses central thermoregulatory pathways and peripheral vascular dynamics.

Dosage and Administration Information

Lemsip Max Cold & Flu is administered via the oral route following mandatory preparation of the powder. The official dosage form is a powder for oral solution, with each sachet containing 1000 mg of Paracetamol and 12.2 mg of Phenylephrine Hydrochloride. This preparation requires the contents of one sachet to be dissolved by stirring in a mug of hot, non-boiling water. The resulting solution is then consumed once it has cooled to a drinkable temperature, and it may be sweetened to taste as preferred.

The standard unit dose is one sachet, approved for use in adults, the elderly, and adolescents aged 16 years and over. This dose can be repeated as required for symptomatic relief, provided a minimum interval of four hours is observed between administrations. The total intake is strictly limited; individuals must not exceed four sachets within any 24-hour period. Consistent with general principles for analgesic use, the lowest effective dose must be employed for the shortest duration necessary.

This medicine is not to be given to children under 16 years of age. Population-specific instructions note that for patients with renal or hepatic impairment, or for frail elderly subjects, a reduction in the dose or an increase in the interval between administrations may be appropriate. If symptoms persist or worsen after 3 to 5 days of self-administration, professional consultation is required. If a dose is missed, the next dose should be taken only when needed, maintaining the minimum interval without doubling the previous quantity.

Recent Clinical Evidence

Evidence for Symptom Relief in Colds and Flu (Paracetamol and Phenylephrine Combination)

Research has explored how symptoms change during periods of heightened cold and flu activity when using products that contain a combination of paracetamol (an analgesic) and phenylephrine (a decongestant). This active combination was studied for its use in conditions characterized by fluctuating or episodic manifestations, typically focusing on adults with recent onset of a cold or flu-like illness. The core study designs used in this research are short-term, randomized, placebo-controlled trials, which applied methods examining patient-reported experiences over defined time intervals.

In these trials, researchers monitored changes in what are known as Total Symptom Scores (TSS), which capture outcomes related to physical discomfort like headache, fever, and nasal congestion, along with outcomes reflecting daily functioning. Findings describe patterns observed in the studies, often reporting patterns where measurements varied between the active combination and the placebo group at specific time points. However, findings were mixed and studies report how symptoms evolved only in the observed populations, generally over a very short period of time. Research highlights changes measured during the study period, but the evidence is limited and often heterogeneous across different formulations and trials.

Evidence in Specific Populations and Long-Term Data

Most research exploring short-term symptom changes was focused on the general adult population. However, data for certain groups remain insufficient, and evidence in special populations is limited. Specifically, comparative evidence for specific outcomes is limited for combination cold and flu products in older adults and individuals with certain comorbid conditions or functional limitations.

Studies monitoring cold and flu symptom relief are typically relevant in trials assessing short-term or episodic symptom patterns, meaning that follow-up durations were limited across the overall evidence base. Because of this, long-term effects are not fully established; evidence remains limited regarding the durability of the measured effect beyond the initial short window. Research does not determine whether an individual will experience sustained changes or what happens to symptom patterns over extended periods.

Key Studies & References Systematic review and meta-analysis of the effectiveness of paracetamol (acetaminophen) in reducing fever and pain: Clinical evidence for use in various conditions

Frequently Asked Questions (FAQ)

Common questions about Lemsip Max Cold & Flu (FAQ)

Q: How long does it usually take for the effects of Lemsip Max Cold & Flu to begin?

Official information indicates that the pain-relieving effect of the Paracetamol component typically begins within 30 minutes following administration. While the decongestant component's speed of action is not consistently defined in every regulatory document, the overall purpose of the medicine is to provide short-term symptomatic relief.

Q: Is it possible to take Lemsip Max Cold & Flu while taking antibiotics?

General interaction statements for the entire class of antibiotics are not typically provided in regulatory documents. However, caution is advised when using Paracetamol alongside the antibiotic Flucloxacillin. This is due to a specific, documented risk of a blood and fluid abnormality (high anion gap metabolic acidosis) when Paracetamol is used with Flucloxacillin, particularly in patients with certain pre-existing risk factors.

Q: Are there any common side effects involving the stomach or gut?

Official regulatory documents report the occurrence of nausea and vomiting among the commonly observed adverse effects. Other gastrointestinal effects, such as abdominal pain or dry mouth, have also been reported in the safety information.

Q: Does Lemsip Max Cold & Flu interact with anti-depressant medications?

Regulatory documents state that this medicine is strictly contraindicated (must not be used) if a person is currently taking or has recently stopped taking Monoamine Oxidase Inhibitors (MAOIs), a class of antidepressant. Official guidance also advises caution when using the medicine with other antidepressants, such as Tricyclic Antidepressants.

Q: Is it safe to drive or operate machinery after taking this medicine?

Official labels do not provide direct driving instructions but report that nervous system effects like dizziness, restlessness, and anxiety are possible side effects. If a person experiences any of these effects, official guidance recommends avoiding driving or operating machinery.

Q: Can Lemsip Max Cold & Flu cause heart palpitations or a fast heartbeat?

Yes, official safety profiles list both tachycardia (a fast heartbeat) and palpitations (the feeling of an irregular or strong heartbeat) as possible adverse effects. These effects are associated with the Phenylephrine component of the medicine.

Q: What is the typical duration that Lemsip Max Cold & Flu works to relieve symptoms?

The official dosing schedule indicates that a repeat dose may be taken after a minimum interval of four hours. The four-hour interval between doses reflects the period during which the medicine is intended to provide relief before the next administration is potentially needed.

Q: Is Lemsip Max Cold & Flu the same as Lemsip Max All in One?

Lemsip Max Cold & Flu Powder typically contains Paracetamol and Phenylephrine Hydrochloride. Lemsip Max All in One products often have a different ingredient profile, as they usually contain those two ingredients plus an expectorant like Guaifenesin, and sometimes Caffeine. These products are therefore different formulations, reflecting variations in their ingredient combinations.

Q: Are there any specific foods or drinks to avoid when using this medicine?

Official regulatory documents strongly advise against taking this medicine with alcohol (ethanol). This is because chronic or excessive alcohol intake may increase the risk of liver damage (hepatotoxicity) associated with the Paracetamol component.

Q: Is Lemsip Max Cold & Flu suitable for people who have diabetes?

A pre-existing condition of diabetes mellitus is officially listed as a contraindication for this medicine. Additionally, regulatory documents state that the powder for oral solution formulation contains sucrose (sugar), which patients with diabetes mellitus should take into account.

Q: Does Lemsip Max Cold & Flu contain caffeine, and what is its purpose?

Some specific product variations, such as the 'Day' capsules or certain powder formulations, do include Caffeine. When present, Caffeine is included for its action as a mild stimulant to help relieve symptoms of lethargy and fatigue associated with colds and flu.

Q: What are the main differences between Lemsip Max and regular Lemsip products?

Lemsip Max products are officially named 'Max' because they contain the maximum approved dose of Paracetamol per unit dose, which is typically 1000 mg in a sachet. Standard 'Lemsip' products typically contain lower amounts of the active ingredients compared to the Max formulations.

Q: Is there a risk of becoming addicted to Lemsip Max Cold & Flu?

Official regulatory documents do not identify this medicine as having habit-forming ingredients. However, official documents caution that for any over-the-counter medicine, prolonged use beyond the recommended period is not advised without medical supervision.

Q: Does Lemsip Max Cold & Flu contain any ingredients that may cause allergic reactions?

Yes. Official documents state that the product is contraindicated if a person is allergic to the active ingredients (Paracetamol or Phenylephrine) or any of the other ingredients (excipients). The full list of other ingredients is provided in the patient information leaflet.

Q: Can taking this medicine affect the results of certain lab tests?

Official labeling documents indicate that the Paracetamol component may interfere with the results of certain medical tests, such as some blood glucose tests. Regulatory warnings indicate that if changes in test results are noted, professional consultation may be appropriate.

Q: Does Lemsip Max Cold & Flu contain lactose or phenylalanine?

Specific formulations of the powder sachets contain lactose. They also contain aspartame, which is a source of phenylalanine. Patients with specific intolerances (lactose) or the genetic disorder phenylketonuria (PKU) are officially advised to take this into account.

Q: Can Lemsip Max Cold & Flu cause dizziness or restlessness?

Yes, official adverse event lists, categorized under Nervous System Disorders, include reports of dizziness, restlessness, insomnia, and anxiety as possible side effects associated with the medicine.

Q: Does this medicine contain an anti-inflammatory ingredient like ibuprofen?

No. The active ingredients are officially defined as Paracetamol (an analgesic and antipyretic) and Phenylephrine Hydrochloride (a decongestant). Official documents confirm the medicine does not contain Ibuprofen or any other drug officially classified as a non-steroidal anti-inflammatory drug (NSAID).

How should Lemsip Max Cold & Flu be stored and disposed of?

Storage and Disposal of Lemsip Max Cold & Flu

The storage and disposal requirements for Lemsip Max Cold & Flu are defined by regulatory labeling to ensure product stability and safety. The official profile addresses temperature control, packaging, and child protection.

Storage Requirements

Requirement	Condition
Temperature	Do not store above mathbf25^circC.
Protection	Keep the powder formulation in a dry place.
Packaging	Store in the original package.
Child Safety	Must be kept out of the sight and reach of children.

Disposal Instructions

Official labeling states there are no special requirements for disposal of unused or expired Lemsip Max Cold & Flu. The product is not classified as hazardous waste, and instructions do not prohibit general disposal methods.

Lemsip Max Cold & Flu